# Origin Biomed Inc: Form D filing

Origin Biomed Inc, a company in Halifax, filed a Form D with the SEC in 2009. The latest, on May 27, 2009, reports $3.3 million sold of a $4 million offering to 7 investors.

Find out what Origin Biomed Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Origin%20Biomed%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Origin%20Biomed%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Forigin-biomed-inc-1407422)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Origin%20Biomed%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Origin%20Biomed%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Forigin-biomed-inc-1407422)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in other industries](https://specstream.ai/data/form-d/industry/other): 9,873 rows, by operating companies, filed since November 1, 2024, $178.73, or the new rows each week for $19.10 a month. Buy: https://specstream.ai/data/form-d/industry/other
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 5162 Duke Str, SUITE 500, Halifax, B3J 1
- Phone: (902) 423-5745
- Industry: Other
- Entity type: Corporation
- Incorporated in: A5
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1407422

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 27, 2009 | New notice | $3,994,634 | $3,266,634 | $728,000 | 7 | Apr 21, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1407422/000140742209000003/0001407422-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Barry Tuner | Director |  |
| Gordon Buchan | Director |  |
| Ron Mitton | Director |  |
| Robert Cervelli | Director |  |
| Aki Georgacacos | Director |  |
| Peter MacNeil | Director |  |
| Murray McLaughlin | Director |  |

[Every Form D from the week of May 25, 2009](https://specstream.ai/data/form-d/week/2009-05-25) · [All recent Other filings](https://specstream.ai/data/form-d/industry/other)

Read from SEC EDGAR. Amount sold is what Origin Biomed Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).